Participants
Participate
Current Trials
NZCR Screening HQ
Payment Forms
FAQ’s
Sponsors
Why NZCR?
Our Expertise
Our Facilities and Services
About Us
About NZCR
Meet the Team
News
Current Trials
Register your Interest
我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278
AKL & HAM - 0800 788 3437
|
CHC & WLG - 0800 862 278
|
News
Register Interest
Participants
Participate
Current Trials
NZCR Screening HQ
Payment Forms
FAQ’s
Sponsors
Why NZCR?
Our Expertise
Our Facilities and Services
About Us
About NZCR
Meet the Team
News
Current Trials
Register your Interest
NZCR leading the world in gene editing research
Home
/
NZCR leading the world in gene editing research
Earlier this month, at NZCR in Auckland, a New Zealander was the first person in the world to be injected with gene-editing instructions to try and modify a single part of their DNA to stop it producing bad cholesterol. Past laboratory results, resulted in a 70 percent reduction in cholesterol levels.
Dr. Andrew Bellinger is the chief scientific and medical officer of Verve Therapeutics and he joined Mike Hosking to discuss this this.
https://www.iheart.com/podcast/211-the-mike-hosking-breakfast-24837692/episode/dr-andrew-bellinger-verve-therapeutics-on-gene-99773864/
#NZCR
advancing global health
Share
Share this...
Facebook
Pinterest
Twitter
Linkedin
Get in touch today
NZCR Advancing global health
Contact Us Today